Lenacapavir: After FDA approval, HIV pre-exposure prophylaxis injectable moving closer to EU approval
In a trial in South Africa and Uganda, there were zero HIV infections among 2,134 participants who received Lenacapavir PrEP injectable once in six months. Gilead Sciences has licensed four pharmaceutical manufacturers in India to make and sell generic Lenacapavir
Read More